Nicorette Invisi Transdermal Patch

Nicorette Invisi Transdermal Patch Use In Pregnancy & Lactation

nicotine

Manufacturer:

Johnson & Johnson

Distributor:

Zuellig Pharma
Full Prescribing Info
Use In Pregnancy & Lactation
Nicotine passes to the foetus and affects its breathing movements and circulation. The effect on the circulation is dose-dependent. Therefore, the pregnant smoker should always be advised to stop smoking completely without the use of nicotine replacement therapy. The risk of continued smoking may pose greater hazard to the foetus as compared with the use of nicotine replacement products in a supervised smoking cessation program. Use of Nicorette Invisi Transdermal Patch by the pregnant smoker should only be initiated after advice from a healthcare professional.
Nicorette passes freely into breast milk in quantities that may affect the infant, even at therapeutic doses. The use of Nicorette Invisi Transdermal Patch should therefore be avoided when breastfeeding. Should smoking cessation not be achieved, use of the Nicorette Invisi Transdermal Patch by breastfeeding smokers should only be initiated after advice from a healthcare professional.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in